BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12723737)

  • 1. Does C-reactive protein represent an oxidative stress marker in cardiovascular disease?
    Korantzopoulos P; Papaioannides D; Galaris D; Kokkoris S
    Int J Clin Pract; 2003 Apr; 57(3):252. PubMed ID: 12723737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Emerging risk factors for cardiovascular disease].
    Demant T
    Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418
    [No Abstract]   [Full Text] [Related]  

  • 3. Smoking interacts with sleep apnea to increase cardiovascular risk.
    Lavie L; Lavie P
    Sleep Med; 2008 Mar; 9(3):247-53. PubMed ID: 17513169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hold, raise, or fold: C-reactive protein, hormone therapy, and cardiovascular risk.
    Stuenkel CA
    Menopause; 2011 Jan; 18(1):8-10. PubMed ID: 21187728
    [No Abstract]   [Full Text] [Related]  

  • 5. C-reactive protein and coronary heart disease.
    Foody JM; Gotto AM; Wenger N
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
    [No Abstract]   [Full Text] [Related]  

  • 6. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
    Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
    Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and cardiovascular risk in the Framingham Study.
    Ridker P; Rifai N; Koenig W; Blumenthal RS
    Arch Intern Med; 2006 Jun; 166(12):1327-8; author reply 1328. PubMed ID: 16801524
    [No Abstract]   [Full Text] [Related]  

  • 8. C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
    Wethal T; Haugnes HS; Kjekshus J; Småstuen MC; Ueland T; Aukrust P; Fosså SD
    Eur J Cancer; 2010 Dec; 46(18):3425-33. PubMed ID: 20832295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: "plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies".
    Meerwaldt R; Links T; Zeebregts C; Smit A
    Am J Epidemiol; 2008 Mar; 167(6):756-7. PubMed ID: 18296707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic value of C-reactive protein in ischemic cardiopathy].
    Bazzino O; Natale E
    Medicina (B Aires); 2001; 61(2):239-42. PubMed ID: 11374151
    [No Abstract]   [Full Text] [Related]  

  • 11. [C-reactive protein--a molecule that changed cardiology].
    Ostádal P
    Vnitr Lek; 2004 Nov; 50(11):809-11. PubMed ID: 15648958
    [No Abstract]   [Full Text] [Related]  

  • 12. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A commentary to the article by Dvoráková, Poledne: "An ultrasensitive C-reactive protein assay--a new parameter of a cardiovascular risk" sent from the Laboratory for Aterosclerosis Investigation at IKEM Prague].
    Málek F
    Vnitr Lek; 2004 Nov; 50(11):807-9. PubMed ID: 15648957
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.
    Nuttall SL; Heaton S; Piper MK; Martin U; Gordon C
    Rheumatology (Oxford); 2003 Jun; 42(6):758-62. PubMed ID: 12730535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects.
    Dohi Y; Takase H; Sato K; Ueda R
    Int J Cardiol; 2007 Jan; 115(1):63-6. PubMed ID: 16759717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial function, CRP and oxidative stress in chronic kidney disease.
    Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
    J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein potential risk factor for cardiovascular disease].
    Tornvall P; Pernow J; Hansson LO
    Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and cardiovascular disease: are we looking in the right direction?
    Hashimoto J; O'Rourke MF
    J Hypertens; 2006 Oct; 24(10):2115. PubMed ID: 16957575
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alcohol-free beer on lipid profile and parameters of oxidative stress and inflammation in elderly women.
    Martínez Alvarez JR; Bellés VV; López-Jaén AB; Marín AV; Codoñer-Franch P
    Nutrition; 2009 Feb; 25(2):182-7. PubMed ID: 18947976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.